Contract research organizations (CROs) ICON PLC (NASDAQ:ICLR) and Charles River Laboratories (NYSE:CRL) have been in the news lately due to recent interest in CROs. However, many hedge funds are holding or adding to their positions in another smaller, niche CRO: Medpace Holdings Inc (NASDAQ:MEDP). The stock has tumbled 23% over the past year, with roughly half of that coming year to date, but a long list of hedge funds are hanging on despite that.
Read hedge fund letters here
Although Vulcan Value Partners appears to have first owned Medpace in Q2 2021, it established a new position in the company during the first quarter, according to its Q1 2025 letter to investors. LVS...
Login required to continue reading.
Setup a free account to get access to this article (no credit card required).
View Full Article
